Misonix, Inc. MSON

Misonix, Inc. General and Administrative Expenses 2011-2026 | MSON

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Misonix, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
18 M	11.9 M	9.06 M	9.6 M	7.36 M	5.98 M	4.69 M	4.45 M	4.38 M	4.5 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
18 M	4.38 M	7.99 M

General and Administrative Expenses of other stocks in the Medical devices industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
Align Technology ALGN	1.76 B	$ 176.83	5.97 %	$ 13.2 B	USA
Alphatec Holdings ATEC	499 M	$ 11.66	5.71 %	$ 1.75 B	USA
GenMark Diagnostics, Inc. GNMK	25.6 M	-	-	$ 1.77 B	USA
Acutus Medical AFIB	14.1 M	-	-26.83 %	$ 2.62 M	USA
AxoGen AXGN	44.6 M	$ 34.0	9.71 %	$ 1.57 B	USA
AdaptHealth Corp. AHCO	382 M	$ 12.18	2.01 %	$ 1.65 B	USA
Allied Healthcare Products AHPI	7.11 M	-	3.58 %	$ 2.21 M	USA
Conformis CFMS	28.8 M	-	-	$ 16.4 M	USA
Obalon Therapeutics, Inc. OBLN	8.78 M	-	-5.86 %	$ 30.6 M	USA
Bio-Rad Laboratories BIO	814 M	$ 281.15	1.13 %	$ 7.93 B	USA
Cardiovascular Systems CSII	171 M	-	0.15 %	$ 844 M	USA
Cytosorbents Corporation CTSO	35.6 M	$ 0.62	1.67 %	$ 38.6 M	USA
Bruker Corporation BRKR	894 M	$ 38.25	4.31 %	$ 5.7 K	USA
Boston Scientific Corporation BSX	6.89 B	$ 62.56	1.15 %	$ 92.6 B	USA
Dynatronics Corporation DYNT	8.46 M	-	14.99 %	$ 929 K	USA
Apollo Endosurgery APEN	20.6 M	-	-	$ 475 M	USA
Electromed ELMD	39.3 M	$ 24.4	2.61 %	$ 206 M	USA
Second Sight Medical Products EYES	1.11 M	-	-0.97 %	$ 54.4 M	USA
ClearPoint Neuro CLPT	16.5 M	$ 9.17	1.1 %	$ 260 M	USA
GBS GBS	8.88 M	-	-0.57 %	$ 7.12 M	USA
Globus Medical GMED	1.18 B	$ 91.96	2.13 %	$ 12.4 B	USA
CryoLife, Inc. CRY	141 M	-	-4.14 %	$ 702 M	USA
Avinger AVGR	14.1 M	-	-20.74 %	$ 369 K	USA
Inogen INGN	67.4 M	$ 6.67	-1.91 %	$ 177 M	USA
Inspire Medical Systems INSP	625 M	$ 53.38	-1.89 %	$ 1.57 B	USA
Axonics Modulation Technologies AXNX	40.2 M	-	-	$ 3.31 B	USA
IRIDEX Corporation IRIX	7.73 M	$ 1.03	-	$ 17.4 M	USA
Integer Holdings Corporation ITGR	212 M	$ 87.48	2.78 %	$ 3.04 B	USA
Invacare Corporation IVC	227 M	-	-	$ 24.7 M	USA
Aziyo Biologics AZYO	15.1 M	-	1.37 %	$ 20.5 M	USA
Soliton, Inc. SOLY	8.46 M	-	-1.42 %	$ 435 M	USA
OrthoPediatrics Corp. KIDS	120 M	$ 16.01	1.59 %	$ 376 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	4.88 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	8.5 M	-	0.03 %	$ 1.58 B	Israel
Neovasc NVCN	14.7 M	-	-	$ 111 M	Canada
LivaNova PLC LIVN	549 M	$ 64.66	1.76 %	$ 3.53 B	Britain
LENSAR LNSR	45.2 M	$ 5.53	-1.78 %	$ 66.1 M	USA
Butterfly Network BFLY	39.8 M	$ 4.14	2.22 %	$ 876 M	USA
Intersect ENT, Inc. XENT	98.6 M	-	-	$ 955 M	USA
EDAP TMS S.A. EDAP	5.9 M	$ 3.37	-0.88 %	$ 126 M	France
Myomo MYO	14 M	$ 0.68	0.44 %	$ 28.5 M	USA
NanoVibronix NAOV	3.46 M	-	-	$ 1.08 M	USA
BIOLASE BIOL	10.2 M	-	-13.19 %	$ 166 K	USA
Delcath Systems DCTH	43.5 M	$ 9.85	1.86 %	$ 353 M	USA
BioSig Technologies BSGM	67.5 M	-	37.08 %	$ 85.7 M	USA
Natus Medical Incorporated NTUS	52.8 M	-	1.94 %	$ 1.05 B	USA
Nevro Corp. NVRO	310 M	-	-	$ 217 M	USA